Compositions for pulmonary delivery of long-acting muscarinic antagonists and long-acting B2 adrenergic receptor agonists and associated methods and systems

Details for Australian Patent Application No. 2010253776 (hide)

Owner Pearl Therapeutics, Inc.

Inventors Vehring, Reinhard; Hartman, Michael Steven; Smith, Adrian Edward; Joshi, Vidya B.; Dwivedi, Sarvajna Kumar

Agent Shelston IP

Pub. Number AU-A-2010253776

PCT Pub. Number WO2010/138868

Priority 61/182,565 29.05.09 US; 61/258,172 04.11.09 US; 61/309,365 01.03.10 US; 61/345,536 17.05.10 US

Filing date 28 May 2010

Wipo publication date 2 December 2010

International Classifications

A61K 9/12 (2006.01) Medicinal preparations characterised by special physical form - Aerosols

Event Publications

24 November 2011 PCT application entered the National Phase

  PCT publication WO2010/138868 Priority application(s): WO2010/138868

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010253784-Fusion formable sodium free glass

2010253774-Identifying terms to include in content